These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3178818)

  • 21. Prostaglandin A inhibits replication of human immunodeficiency virus during acute infection.
    Ankel H; Turriziani O; Antonelli G
    J Gen Virol; 1991 Nov; 72 ( Pt 11)():2797-800. PubMed ID: 1940869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of retrovirus-induced syncytium formation by photoproducts of a brominated 1,8-naphthalimide compound.
    Chanh TC; Lewis DE; Judy MM; Sogandares-Bernal F; Michalek GR; Utecht RE; Skiles H; Chang SC; Matthews JL
    Antiviral Res; 1994 Oct; 25(2):133-46. PubMed ID: 7847875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimitotic and antiviral activities of Kelletinin A in HTLV-1 infected MT2 cells.
    Silvestri I; Albonici L; Ciotti M; Lombardi MP; Sinibaldi P; Manzari V; Orlando P; Carretta F; Strazzullo G; Grippo P
    Experientia; 1995 Nov; 51(11):1076-80. PubMed ID: 7498449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment of a biological assay system for human retroviral protease activity.
    Yoshida A; Piroozmand A; Sakurai A; Fujita M; Uchiyama T; Kimura T; Hayashi Y; Kiso Y; Adachi A
    Microbes Infect; 2005 May; 7(5-6):820-4. PubMed ID: 15893491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sulfation of polysaccharides generates potent and selective inhibitors of human immunodeficiency virus infection and replication in vitro.
    Nakashima H; Yoshida O; Tochikura TS; Yoshida T; Mimura T; Kido Y; Motoki Y; Kaneko Y; Uryu T; Yamamoto N
    Jpn J Cancer Res; 1987 Nov; 78(11):1164-8. PubMed ID: 2447045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of the human immunodeficiency virus-1 protease and human immunodeficiency virus-1 replication by bathocuproine disulfonic acid Cu1+.
    Davis DA; Branca AA; Pallenberg AJ; Marschner TM; Patt LM; Chatlynne LG; Humphrey RW; Yarchoan R; Levine RL
    Arch Biochem Biophys; 1995 Sep; 322(1):127-34. PubMed ID: 7574666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GLQ223: an inhibitor of human immunodeficiency virus replication in acutely and chronically infected cells of lymphocyte and mononuclear phagocyte lineage.
    McGrath MS; Hwang KM; Caldwell SE; Gaston I; Luk KC; Wu P; Ng VL; Crowe S; Daniels J; Marsh J
    Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2844-8. PubMed ID: 2704750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate.
    Sandstrom EG; Kaplan JC; Byington RE; Hirsch MS
    Lancet; 1985 Jun; 1(8444):1480-2. PubMed ID: 2409414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle.
    Witvrouw M; Fikkert V; Pluymers W; Matthews B; Mardel K; Schols D; Raff J; Debyser Z; De Clercq E; Holan G; Pannecouque C
    Mol Pharmacol; 2000 Nov; 58(5):1100-8. PubMed ID: 11040059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
    Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R
    Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor necrosis factor enhances replication of human immunodeficiency virus (HIV) in vitro.
    Ito M; Baba M; Sato A; Hirabayashi K; Tanabe F; Shigeta S; De Clercq E
    Biochem Biophys Res Commun; 1989 Jan; 158(1):307-12. PubMed ID: 2912452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.
    Furman PA; Fyfe JA; St Clair MH; Weinhold K; Rideout JL; Freeman GA; Lehrman SN; Bolognesi DP; Broder S; Mitsuya H
    Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8333-7. PubMed ID: 2430286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel naphthalenedisulfonic acid anti-HIV-1 agents. Synthesis and activity against reverse transcriptase, virus replication and syncytia formation.
    Mohan P; Singh R; Baba M
    Drug Des Discov; 1991 Nov; 8(1):69-82. PubMed ID: 1725723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substances affecting the infection and replication of human immunodeficiency virus (HIV).
    Yamamoto N; Harada S; Nakashima H
    AIDS Res; 1986 Dec; 2 Suppl 1():S183-9. PubMed ID: 3030346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro anti-human immunodeficiency virus type 1 activity of biliverdin, a bile pigment.
    Mori H; Otake T; Morimoto M; Ueba N; Kunita N; Nakagami T; Yamasaki N; Taji S
    Jpn J Cancer Res; 1991 Jul; 82(7):755-7. PubMed ID: 1715337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiviral action of oligodeoxyguanylic acids against human immunodeficiency virus type 1.
    Fujihashi T; Sakata T; Kaji A; Kaji H
    AIDS Res Hum Retroviruses; 1995 Apr; 11(4):461-71. PubMed ID: 7543270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro suppression of HIV-1 replication by ajoene [(e)-(z)-4,5,9-trithiadodeca-1,6,11-triene-9 oxide].
    Walder R; Kalvatchev Z; Garzaro D; Barrios M; Apitz-Castro R
    Biomed Pharmacother; 1997; 51(9):397-403. PubMed ID: 9452790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Catuaba extracts on microbial and HIV infection.
    Manabe H; Sakagami H; Ishizone H; Kusano H; Fujimaki M; Wada C; Komatsu N; Nakashima H; Murakami T; Yamamoto N
    In Vivo; 1992; 6(2):161-5. PubMed ID: 1525337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of HIV infection by baicalin--a flavonoid compound purified from Chinese herbal medicine.
    Li BQ; Fu T; Yan YD; Baylor NW; Ruscetti FW; Kung HF
    Cell Mol Biol Res; 1993; 39(2):119-24. PubMed ID: 7693133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of replication of the etiologic agent of acquired immune deficiency syndrome (human T-lymphotropic retrovirus/lymphadenopathy-associated virus) by avarol and avarone.
    Sarin PS; Sun D; Thornton A; Müller WE
    J Natl Cancer Inst; 1987 Apr; 78(4):663-6. PubMed ID: 2435942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.